Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the
remodeling of pulmonary blood vessels. If left unaddressed, PAH can lead to right heart …

Pulmonary arterial hypertension (PAH) is a rare, chronic disease of the pulmonary
vasculature that is associated with poor outcomes. Its pathogenesis is multifactorial and …

Abstract MiR-21-5p is an anti-apoptotic miRNA known to mediate the protective effect of
mesenchymal stromal cell-secreted exosomes (MSC-Exo) against oxidative stress-induced …

Abstract Aims N 6-methyladenosine (m 6 A) is the most prevalent internal chemical RNA
modification in mammal mRNAs. Accumulating evidence has shown the critical role of m 6 A …

Rationale: Hypoxia has been proved to contribute to aggressive phenotype of cancers, while
functional and regulatory mechanism of long noncoding RNA (lncRNA) in the contribution of …

Background Hepatocellular carcinoma (HCC) is one of the most lethal cancer, mainly
attributing to its high tendency to metastasis. Vascular invasion provides a direct path for …

Pulmonary arterial hypertension (PAH) is a disease with complex pathobiology, significant
morbidity and mortality, and remains without a cure. It is characterized by vascular …

Hypoxic pulmonary hypertension (HPH) is a serious and potentially devastating disorder of
the pulmonary circulation with complicated mechanisms. Long non-coding RNA (lncRNA) …

The expression and function of long noncoding RNAs (lncRNAs) in the development of
hypoxic pulmonary hypertension (HPH), especially in the proliferation of pulmonary artery …

Hypertension is a multifactorial disorder that involves complex genetic and environmental
factors. Vascular smooth muscle cells (VSMCs) are important components of blood vessels …